- Nucleic acid amplification test
- Viral Culture Tests
- Antibody-Antigen Based tests
Herpes Marker Testing Market is expected to grow at a CAGR of 6.4% from 2023-2029. Driving factors for the global herpes marker testing market include a rise in prevalence of the herpes infections across the globe. In addition, a rise in government support for the development of accurate diagnostics for diseases like herpes and growing awareness related to the available diagnostic tests for herpes are expected to boost the market growth over the forecast period. Numerous regional and international firms compete in the global market for herpes marker testing products, which is constantly evolving due to technology improvements and new product introductions. The prevalence of herpes in the population, increased government backing, growing awareness, rising healthcare expenditures, new product introductions, and a growing focus on evidence-based medicine are all driving the herpes marker testing industry. Some obstacles are limiting market revenue growth, such as limited access to diagnostic services in rural places, insufficient R&D initiatives, pricing pressures, and severe restrictions. To stay competitive in the global market, companies are working on acquisitions, mergers, and new product approvals and launches. The market for herpes marker testing is separated into three types of tests: viral culture tests, nucleic acid amplification-based kits, and antibody/antigen-based kits. Because of the large product availability and high physician preference for this test type, the antibody/antigen-based kits segment dominates the market with over 50% market share estimated during the projection period. However, due to the increased use of PCR technique in diagnosis due to its high sensitivity, specificity, and low time consumption, the nucleic acid amplification-based kits segment is expected to develop at the fastest rate over the projection period.
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Advancements in biotechnology and new product launch in herpes marker testing projected to bolster the market share. However, poor access of diagnostics in the under developing countries, cost involved in biomarker development and prices of diagnosis are expected to hamper the global herpes marker testing market over the forecast period.
The herpes marker testing market size was valued at USD x billion in 2022
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), BioMérieux SA (France), DiaSorin (Italy), Hoffmann-La Roche Ltd. (Switzerland), Luminex Corporation (U.S.)
1.Executive Summary |
2.Global Herpes Marker Testing Market Introduction |
2.1.Global Herpes Marker Testing Market - Taxonomy |
2.2.Global Herpes Marker Testing Market - Definitions |
2.2.1.Test Type |
2.2.2.Virus Type |
2.2.3.Application |
2.2.4.By End User |
2.2.5.Region |
3.Global Herpes Marker Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4.Global Herpes Marker Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5.Global Herpes Marker Testing Market By Test Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Nucleic acid amplification test |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Viral Culture Tests |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Antibody-Antigen Based tests |
5.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
6.Global Herpes Marker Testing Market By Virus Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. HSV-1 |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. HSV-2 |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. HSV-1 & HSV-2 |
6.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
7.Global Herpes Marker Testing Market By Application, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. Clinical Diagnosis |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Research Use |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
8.Global Herpes Marker Testing Market By By End User, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. Hospitals |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Research Laboratories |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Diagnostic Centres |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Others |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
9.Global Herpes Marker Testing Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. North America |
9.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.1.3. Market Opportunity Analysis |
9.2. Europe |
9.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.2.3. Market Opportunity Analysis |
9.3. Asia Pacific (APAC) |
9.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.3.3. Market Opportunity Analysis |
9.4. Middle East and Africa (MEA) |
9.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.4.3. Market Opportunity Analysis |
9.5. Latin America |
9.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
9.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
9.5.3. Market Opportunity Analysis |
10.North America Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Test Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Nucleic acid amplification test |
10.1.2.Viral Culture Tests |
10.1.3.Antibody-Antigen Based tests |
10.2. Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.HSV-1 |
10.2.2.HSV-2 |
10.2.3.HSV-1 & HSV-2 |
10.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.Clinical Diagnosis |
10.3.2.Research Use |
10.4. By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Hospitals |
10.4.2.Research Laboratories |
10.4.3.Diagnostic Centres |
10.4.4.Others |
10.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.5.1.United States of America (USA) |
10.5.2.Canada |
11.Europe Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Nucleic acid amplification test |
11.1.2.Viral Culture Tests |
11.1.3.Antibody-Antigen Based tests |
11.2. Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.HSV-1 |
11.2.2.HSV-2 |
11.2.3.HSV-1 & HSV-2 |
11.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.Clinical Diagnosis |
11.3.2.Research Use |
11.4. By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.Hospitals |
11.4.2.Research Laboratories |
11.4.3.Diagnostic Centres |
11.4.4.Others |
11.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.5.1.Germany |
11.5.2.France |
11.5.3.Italy |
11.5.4.United Kingdom (UK) |
11.5.5.Spain |
12.Asia Pacific (APAC) Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Nucleic acid amplification test |
12.1.2.Viral Culture Tests |
12.1.3.Antibody-Antigen Based tests |
12.2. Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.HSV-1 |
12.2.2.HSV-2 |
12.2.3.HSV-1 & HSV-2 |
12.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.Clinical Diagnosis |
12.3.2.Research Use |
12.4. By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.Hospitals |
12.4.2.Research Laboratories |
12.4.3.Diagnostic Centres |
12.4.4.Others |
12.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.5.1.China |
12.5.2.India |
12.5.3.Australia and New Zealand (ANZ) |
12.5.4.Japan |
12.5.5.Rest of APAC |
13.Middle East and Africa (MEA) Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Nucleic acid amplification test |
13.1.2.Viral Culture Tests |
13.1.3.Antibody-Antigen Based tests |
13.2. Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.HSV-1 |
13.2.2.HSV-2 |
13.2.3.HSV-1 & HSV-2 |
13.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.Clinical Diagnosis |
13.3.2.Research Use |
13.4. By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Hospitals |
13.4.2.Research Laboratories |
13.4.3.Diagnostic Centres |
13.4.4.Others |
13.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.5.1.GCC Countries |
13.5.2.South Africa |
13.5.3.Rest of MEA |
14.Latin America Herpes Marker Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
14.1. Test Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.1.1.Nucleic acid amplification test |
14.1.2.Viral Culture Tests |
14.1.3.Antibody-Antigen Based tests |
14.2. Virus Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.2.1.HSV-1 |
14.2.2.HSV-2 |
14.2.3.HSV-1 & HSV-2 |
14.3. Application Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.3.1.Clinical Diagnosis |
14.3.2.Research Use |
14.4. By End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.4.1.Hospitals |
14.4.2.Research Laboratories |
14.4.3.Diagnostic Centres |
14.4.4.Others |
14.5. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
14.5.1.Brazil |
14.5.2.Mexico |
14.5.3.Rest of LA |
15. Competition Landscape |
15.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
15.2.1.Abbott Laboratories (U.S.) |
15.2.2.Thermo Fisher Scientific, Inc. (U.S.) |
15.2.3.BioMérieux SA (France) |
15.2.4.DiaSorin (Italy) |
15.2.5.Hoffmann-La Roche Ltd. (Switzerland) |
15.2.6.Luminex Corporation (U.S.) |
15.2.7.Quidel Corporation (U.S.) |
15.2.8.Qiagen N.V. (Germany) |
15.2.9.Merck KGaA (Germany) |
15.2.10.Hologic Inc. (U.S.) |
15.2.11.Norgen Biotek Corp. (Canada) |
15.2.12.Teco Diagnostics (U.S.) |
16. Research Methodology |
17. Appendix and Abbreviations |